Mucous Membrane Decontamination Market - Regional Analysis
North America Market Insights
North America industry is anticipated to hold largest revenue share by 2035. The growth of the market can be attributed majorly to the higher prevalence of autoimmune diseases backed by the presence of a developed healthcare infrastructure and the growing inclination of people and clinicians toward the utilization of novel drugs. For instance, in 2017, approximately 22 million Americans were anticipated to have at least one autoimmune disease. The number is further set to rise exponentially over the forecast period. Additionally, rapid growth in the health expenditure in the region which is expected to increase the spending capacity of people on health care is further anticipated to enlarge the market size over the forecast period. As of 2020, the national health expenditure of the United States was estimated to be around USD 4 trillion.
Asia Pacific Market Insights
Furthermore, the market is also expected to witness notable growth opportunities in the Asia Pacific region with a total market share during the forecast period. rising prevalence of skin infection such as moles, eczema, warts and fungal infection is estimated to propel the market growth over the forecast period. For instance, nearly 85% of the people aged between 30 to 60 are projected to be living with HPV infection, out of which, nearly 75% of them are Chinese and around 2% of them are Indians. Additionally, increasing prevalence or autoimmune disease coupled with rising instances of open surgeries in the region are also expected to boost the growth of the market over the forecast period.
Europe Market Insights
Moreover, the mucous membrane decontamination market is projected to witness moderate growth opportunities in the Europe region by holding a share during the forecast period. Similar factors such as, escalating instances of skin infection and spike in the prevalence of autoimmune diseases are estimated to fuel the market growth during forecast period.
